NCT00304434View on ClinicalTrials.gov

Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Influenza
Interventions
DRUG

Oseltamivir

DRUG

Probenecid

Trial Locations (1)

94304-1207

VA Palo Alto Health Care System, Palo Alto

All Listed Sponsors
collaborator

Brooke Army Medical Center

FED

collaborator

National Institutes of Health (NIH)

NIH

lead

US Department of Veterans Affairs

FED

NCT00304434 - Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies. | Biotech Hunter | Biotech Hunter